Summit Therapeutics' PIPE Round

Summit Therapeutics raised a round of funding on January 14, 2019. Investors include Robert Duggan.

Summit is a biopharmaceutical company focused on the discovery, development and commercialization of medicines for indications for which there are no existing or only inadequate therapies. Summit is c…

Articles about Summit Therapeutics' PIPE Round: